Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Machine Learning-Based Risk Prediction Model and Stratified Management Strategies for Quality of Life in Lung Cancer Patients Undergoing Immunotherapy

NCT06725225 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Zunyi Medical University as lead sponsor.

NCT NCT06725225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06725225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Machine Learning-Based Risk Prediction Model and Stratified Management Strategies for Quality of Life in Lung Cancer Patients Undergoing Immunotherapy
Lead sponsor
Second Affiliated Hospital of Zunyi Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
April 1, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer patients